Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Dysfunction-associated Liver Disease Associated With Poor Food Access and Geographic hot Spots Among Liver Transplant Candidates.

Transplantation·2026
Same author

Large language model chatbot-based text-to-SQL application for database analyses in liver diseases and hepatology research.

JAMIA open·2026
Same author

Evaluating Barriers to Kidney Transplantation in the United States.

Journal of the American Society of Nephrology : JASN·2026
Same author

Hepatology e-consult responses generated by artificial intelligence demonstrate accuracy but require human oversight.

Hepatology communications·2026
Same author

Association of Frailty With Waitlist and Post-Transplant Outcomes in Patients With Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Transplantation proceedings·2026
Same author

Higher Medical Urgency Is Associated With Greater Psychosocial Risk Tolerance in Liver Transplant Listing and Selection.

Transplantation·2026

Related Experiment Video

Updated: Jun 10, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure

Published on: August 14, 2017

Incorporating Model for End-stage Liver Disease Trajectories into Liver Allocation.

Tomohiro Tanaka1,2, Jennifer C Lai3, David Axelrod4,5

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA.

Transplantation
|June 9, 2026
PubMed
Summary
This summary is machine-generated.

Liver transplant allocation can be improved by considering changes in Model for End-stage Liver Disease (MELD) scores. Dynamic MELD scores, incorporating MELD change and velocity, better predict mortality risk than static MELD alone.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Experiment Videos

Last Updated: Jun 10, 2026

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure
07:29

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure

Published on: August 14, 2017

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Area of Science:

  • Organ transplantation research
  • Medical informatics
  • Health services research

Background:

  • Current liver transplant (LT) allocation relies on static Model for End-stage Liver Disease (MELD) scores.
  • Disease trajectory, indicated by MELD score changes (ΔMELD), may offer additional prognostic insights.
  • Dynamic MELD metrics could enhance continuous distribution-based LT allocation.

Purpose of the Study:

  • To evaluate the prognostic value of MELD score dynamics (change and velocity) in liver transplant candidates.
  • To develop and assess dynamic MELD-based scores for improved risk stratification.
  • To determine if MELD dynamics can inform real-time acuity-based LT allocation.

Main Methods:

  • Analysis of adult LT candidates from the OPTN waitlist data (January 2016-June 2024) using a person-day structure.
  • Discrete-time hazard models to assess associations between current MELD, ΔMELD, MELD velocity (ΔMELD/day), and waitlist mortality/dropout at 1 and 90 days.
  • Development of dynamic MELD scores (MELD-DY) and evaluation of predictive performance using NRI and IDI.

Main Results:

  • ΔMELD significantly predicted next-day waitlist mortality, with its prognostic impact varying by MELD severity (interaction OR=1.004).
  • MELD velocity (ΔMELD/day) independently predicted next-day mortality (OR=1.24).
  • Models incorporating ΔMELD/day demonstrated improved prediction of death or dropout compared to static MELD (NRI=0.28).

Conclusions:

  • MELD score dynamics provide crucial prognostic information beyond static MELD values.
  • Dynamic MELD metrics support enhanced real-time risk stratification for liver transplant candidates.
  • Incorporating MELD dynamics can optimize acuity-based liver transplant allocation.